PSP Research LLC
CIK
2106939
Location
LAS VEGAS, NV
Portfolio Value
Small
$187,882,229
Diversification
Highly concentrated
Filing Date
Global Rank
#6,677
/ 8,798
▲ 1593
· as of Jun 2026
Top Industry
Biotechnology
91.7%
3Y Alpha vs SPY
+21.9%
Period ended 3 months ago
Filed Jul 9, 2026 · 3mo
3 quarters · since Dec 2025
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
75 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
48.0%
−3.5 pts
Top 5
86.5%
+25.5 pts
Top 10
88.0%
+23.2 pts
HHI
3,715
Highly concentrated+989
Portfolio Trend
3 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Unclassified | 85.5% | $160,671,500 |
| Healthcare | 14.5% | $27,210,729 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| BWX | State Street SPDR Bloomberg International Treasury Bond ETF | +285,100 | 570,000 | $90,202,500 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CMPS | COMPASS Pathways plc | −53,000 | 18,000 | $254,700 | |
| DFTX | Definium Therapeutics, Inc. | −24,800 | 10,000 | $470,400 | |
| ARDX | Ardelyx, Inc. | −20,000 | 60,000 | $306,000 | |
| NTLA | Intellia Therapeutics, Inc. | −6,900 | 20,000 | $338,400 | |
| IMVT | Immunovant, Inc. | −6,200 | 13,000 | $500,890 | |
| RARE | Ultragenyx Pharmaceutical Inc. | −5,100 | 17,000 | $567,630 | |
| GLUE | Monte Rosa Therapeutics, Inc. | −5,000 | 23,000 | $556,600 | |
| PHVS | Pharvaris N.V. | −5,000 | 15,000 | $518,700 | |
| VKTX | Viking Therapeutics, Inc. | −5,000 | 10,000 | $390,100 | |
| CRSP | CRISPR Therapeutics AG | −4,500 | 5,000 | $272,700 | |
| TNGX | Tango Therapeutics, Inc. | −4,400 | 10,000 | $312,600 | |
| HRMY | Harmony Biosciences Holdings, Inc. | −4,283 | 10,000 | $364,100 | |
| KOD | Kodiak Sciences Inc. | −4,000 | 6,000 | $233,760 | |
| KNSA | Kiniksa Pharmaceuticals International, plc | −4,000 | 5,000 | $319,750 | |
| EXEL | Exelixis, Inc. | −3,948 | 8,000 | $435,280 | |
| NRIX | Nurix Therapeutics, Inc. | −3,700 | 25,000 | $606,500 | |
| VERA | Vera Therapeutics, Inc. | −3,000 | 7,000 | $300,370 | |
| BBIO | BridgeBio Pharma, Inc. | −3,000 | 3,000 | $223,440 | |
| NAMS | NewAmsterdam Pharma Co N.V. | −3,000 | 12,000 | $406,680 | |
| TGTX | Tg Therapeutics, Inc. | −3,000 | 10,000 | $549,400 | |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | −2,500 | 2,500 | $243,700 | |
| MIRM | Mirum Pharmaceuticals, Inc. | −2,500 | 2,500 | $292,675 | |
| KYMR | Kymera Therapeutics, Inc. | −2,300 | 4,000 | $458,680 | |
| IMNM | Immunome Inc. | −2,000 | 18,000 | $381,420 | |
| ORKA | Oruka Therapeutics, Inc. | −1,968 | 3,000 | $285,510 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
10 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| LQDA | Liquidia Corp | 5,000 | $398,650 | |
| KRYS | Krystal Biotech, Inc. | 692 | $257,195 | |
| AVBP | ArriVent BioPharma, Inc. | 7,041 | $244,604 | |
| JAZZ | Jazz Pharmaceuticals plc | 971 | $233,981 | |
| RVMD | Revolution Medicines, Inc. | 1,200 | $224,736 | |
| RYTM | Rhythm Pharmaceuticals, Inc. | 2,000 | $222,060 | |
| DNLI | Denali Therapeutics Inc. | 8,463 | $217,668 | |
| ARWR | Arrowhead Pharmaceuticals, Inc. | 2,600 | $211,926 | |
| SRRK | Scholar Rock Holding Corp | 3,827 | $210,485 | |
| CTMX | CytomX Therapeutics, Inc. | 39,400 | $147,750 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
14 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| SERA | Sera Prognostics, Inc. | 2,396,685 | $4,865,270 | |
| TYRA | Tyra Biosciences, Inc. | 16,000 | $612,800 | |
| CYTK | Cytokinetics Inc | 8,300 | $547,053 | |
| AGIO | Agios Pharmaceuticals, Inc. | 15,000 | $507,450 | |
| PRAX | Praxis Precision Medicines, Inc. | 1,500 | $483,285 | |
| INBX | Inhibrx Biosciences, Inc. | 6,927 | $465,702 | |
| ERAS | Erasca, Inc. | 17,327 | $280,350 | |
| CELC | Celcuity Inc. | 2,000 | $228,280 | |
| LEGN | Legend Biotech Corp | 12,000 | $217,080 | |
| — | 2,500 | $210,425 | ||
| UTHR | UNITED THERAPEUTICS Corp | 350 | $207,543 | |
| SMMT | Summit Therapeutics Inc. | 10,223 | $193,828 | |
| CMPX | Compass Therapeutics, Inc. | 30,000 | $158,700 | |
| — | 10,795 | $0 | ||
| No positions match the current search. | ||||
75 tracked positions ·
$187,882,229 total
· filing declares
75 positions · $187,882,190
· as of Jun 30, 2026
Showing 1–50
of 75 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| BWX |
State Street SPDR Bloomberg International Treasury Bond ETF
|
Added | 570,000 | $90,202,500 | 48.01% | |
| AAXJ |
iShares MSCI All Country Asia ex Japan ETF
|
Held | 700,000 | $70,469,000 | 37.51% | |
| RPRX |
Royalty Pharma plc
Healthcare
|
Held | 11,000 | $616,770 | 0.33% | |
| NRIX |
Nurix Therapeutics, Inc.
Healthcare
|
Reduced | 25,000 | $606,500 | 0.32% | |
| INCY |
Incyte Corp
Healthcare
|
Held | 5,300 | $600,808 | 0.32% | |
| ARGX |
Argenx SE
Healthcare
|
Held | 641 | $594,700 | 0.32% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
Held | 8,000 | $585,120 | 0.31% | |
| RAPP |
Rapport Therapeutics, Inc.
Healthcare
|
Held | 14,000 | $583,380 | 0.31% | |
| RARE |
Ultragenyx Pharmaceutical Inc.
Healthcare
|
Reduced | 17,000 | $567,630 | 0.30% | |
| TRVI |
Trevi Therapeutics, Inc.
Healthcare
|
Held | 30,000 | $559,500 | 0.30% | |
| GLUE |
Monte Rosa Therapeutics, Inc.
Healthcare
|
Reduced | 23,000 | $556,600 | 0.30% | |
| TGTX |
Tg Therapeutics, Inc.
Healthcare
|
Reduced | 10,000 | $549,400 | 0.29% | |
| HALO |
Halozyme Therapeutics, Inc.
Healthcare
|
Reduced | 7,000 | $547,890 | 0.29% | |
| IONS |
Ionis Pharmaceuticals Inc
Healthcare
|
Held | 6,800 | $539,172 | 0.29% | |
| PHVS |
Pharvaris N.V.
Healthcare
|
Reduced | 15,000 | $518,700 | 0.28% | |
| ARQT |
Arcutis Biotherapeutics, Inc.
Healthcare
|
Held | 19,700 | $516,534 | 0.27% | |
| AUPH |
Aurinia Pharmaceuticals Inc.
Healthcare
|
Held | 30,000 | $509,100 | 0.27% | |
| NBIX |
Neurocrine Biosciences Inc
Healthcare
|
Reduced | 3,000 | $505,620 | 0.27% | |
| IMVT |
Immunovant, Inc.
Healthcare
|
Reduced | 13,000 | $500,890 | 0.27% | |
| ACAD |
Acadia Pharmaceuticals Inc
Healthcare
|
Held | 19,766 | $500,079 | 0.27% | |
| PTCT |
Ptc Therapeutics, Inc.
Healthcare
|
Held | 6,000 | $489,420 | 0.26% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
Held | 13,000 | $483,730 | 0.26% | |
| IMCR |
Immunocore Holdings plc
Healthcare
|
Held | 15,141 | $480,726 | 0.26% | |
| DFTX |
Definium Therapeutics, Inc.
Healthcare
|
Reduced | 10,000 | $470,400 | 0.25% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
Held | 12,000 | $464,400 | 0.25% | |
| KYMR |
Kymera Therapeutics, Inc.
Healthcare
|
Reduced | 4,000 | $458,680 | 0.24% | |
| DYN |
Dyne Therapeutics, Inc.
Healthcare
|
Held | 20,000 | $444,200 | 0.24% | |
| ALNY |
Alnylam Pharmaceuticals, Inc.
Healthcare
|
Held | 1,465 | $441,008 | 0.23% | |
| TARS |
Tarsus Pharmaceuticals, Inc.
Healthcare
|
Held | 7,000 | $440,580 | 0.23% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
Held | 20,000 | $437,200 | 0.23% | |
| EXEL |
Exelixis, Inc.
Healthcare
|
Reduced | 8,000 | $435,280 | 0.23% | |
|
|
Held | 11,000 | $411,620 | 0.22% | ||
| NAMS |
NewAmsterdam Pharma Co N.V.
Healthcare
|
Reduced | 12,000 | $406,680 | 0.22% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
Reduced | 1,500 | $400,080 | 0.21% | |
| LQDA |
Liquidia Corp
Healthcare
|
NEW | 5,000 | $398,650 | 0.21% | |
| STOK |
Stoke Therapeutics, Inc.
Healthcare
|
Held | 12,000 | $392,640 | 0.21% | |
| VKTX |
Viking Therapeutics, Inc.
Healthcare
|
Reduced | 10,000 | $390,100 | 0.21% | |
| IMNM |
Immunome Inc.
Healthcare
|
Reduced | 18,000 | $381,420 | 0.20% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
Held | 3,000 | $367,740 | 0.20% | |
| HRMY |
Harmony Biosciences Holdings, Inc.
Healthcare
|
Reduced | 10,000 | $364,100 | 0.19% | |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
Held | 7,000 | $355,250 | 0.19% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
Reduced | 4,000 | $355,120 | 0.19% | |
| NTLA |
Intellia Therapeutics, Inc.
Healthcare
|
Reduced | 20,000 | $338,400 | 0.18% | |
| MDGL |
Madrigal Pharmaceuticals, Inc.
Healthcare
|
Held | 600 | $322,170 | 0.17% | |
| KNSA |
Kiniksa Pharmaceuticals International, plc
Healthcare
|
Reduced | 5,000 | $319,750 | 0.17% | |
| ALKS |
Alkermes plc.
Healthcare
|
Held | 6,000 | $314,400 | 0.17% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
Reduced | 10,000 | $312,600 | 0.17% | |
| ARDX |
Ardelyx, Inc.
Healthcare
|
Reduced | 60,000 | $306,000 | 0.16% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
Reduced | 7,000 | $300,370 | 0.16% | |
| MIRM |
Mirum Pharmaceuticals, Inc.
Healthcare
|
Reduced | 2,500 | $292,675 | 0.16% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.